Dongwha Pharm.Co.,Ltd (000020.KS) KSC

Currency In KRW

AD

Valuation

Market Cap174.57B
Enterprise Value279.68B
P/E Ratio8.15
PEG Ratio0.04
Price/Sales Ratio0.29
Price/Book Ratio0.37
Enterprise/Revenue0.49
Enterprise/EBITDA5.98

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.05

Income Statement

Revenue496.39B
Revenue/Share18,516.55
Gross Profit203.33B
EBITDA21.16B
Net Income8.69B
Diluted EPS313.37

Balance Sheet

Total Cash32.45B
Total Cash/Share1,170.88
Total Debt123.64B
Total Debt/Equity0.31
Current Ratio1.22
Book Value Per Share14,995.51

Price History

52-Week Change-14.33
52-Week High7,560
52-Week Low4,450
Moving Average 50 Days5,199.4
Moving Average 200 Days5,610.6

Statistics

Average Volume261,245
Shares Outstanding27.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate245
Trailing Annual Dividend Yield4.61
Payout Ratio0.1
Last Split Factor5:1
Last Split DateJuly 02, 2009
AD